Excelsior Sciences
PrivateLast Round
Series A
Dec 4, 2025
Total Funding Raised
$95M
Company Overview
Excelsior Sciences is a biotechnology company that is developing a new form of chemistry that machines can do and AI can use to accelerate the discovery and manufacture of small molecules.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Advanced Materials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Excelsior Sciences Comps
Public and private peers based on sector, stage, and business model.
Excelsior Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 4, 2025 |
Excelsior Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIT | Series A |
| Deerfield Management | Series A |
| Cornucopian Capital | Series A |
| Khosla Ventures | Series A |
| Empire State Development | Series A |
| Sofinnova Partners | Series A |
| Illinois Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 4, 2025
$95M round completed.
Excelsior Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Excelsior Sciences's valuation, stock price, and market status.
